| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $656.4M | +69.4% |
| Cost of Revenue | $815.8M | +102.5% |
| R&D Expense | $13.2M | +370.4% |
| SG&A Expense | $272.1M | +185.7% |
| Operating Income | $306.1M | +38.6% |
| Pre-tax Income | $616.5M | +122.1% |
| Income Tax | $75.5M | +359.6% |
| Net Income | $541.3M | +107.2% |
| EPS (Basic) | $1.87 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $391.8M | +9.6% |
| Current Assets | $470.4M | -54.3% |
| Total Assets | $6.80B | +241.6% |
| Current Liabilities | $95.2M | +182.0% |
| Long-term Debt | $2.45B | +651.3% |
| Stockholders' Equity | $4.13B | +155.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$677.0M | -114.5% |
| Capital Expenditures | $250.8M | +808.4% |
| Investing Cash Flow | -$3.23B | — |
| Financing Cash Flow | $3.95B | +611.1% |
| Free Cash Flow | -$927.8M | -170.3% |
| +32.6% |
| EPS (Diluted) | $1.72 | +62.3% |